The U.S. Supreme Court will hear Bayer’s appeal to dismiss Roundup cancer lawsuits via federal preemption. This move could lead to the dismissal of thousands of cases and sent Bayer’s stock soaring. Bayer argues EPA approval of its labels should shield it from state failure-to-warn claims. Plaintif…